| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 35.28▼ | 35.29▼ | 35.29▼ | 35.37▼ | 35.45▼ |
| MA10 | 35.28▼ | 35.28▼ | 35.28▼ | 35.32▼ | 35.52▼ |
| MA20 | 35.27▼ | 35.30▼ | 35.34▼ | 35.47▼ | 35.48▼ |
| MA50 | 35.31▼ | 35.35▼ | 35.32▼ | 35.56▼ | 35.12▲ |
| MA100 | 35.37▼ | 35.39▼ | 35.45▼ | 35.49▼ | 34.98▲ |
| MA200 | 35.38▼ | 35.44▼ | 35.49▼ | 35.15▲ | 34.87▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.003▲ | 0.000▲ | -0.008▼ | -0.014▼ | -0.050▼ |
| RSI | 41.613▼ | 34.532▼ | 35.279▼ | 38.542▼ | 48.043▼ |
| STOCH | 58.510 | 80.180▲ | 53.910 | 38.801 | 35.000 |
| WILL %R | -41.176 | -58.333 | -76.190▼ | -87.719▼ | -87.692▼ |
| CCI | -18.817 | -73.491 | -84.379 | -73.352 | -112.655▼ |
| MA | $PHYL Price Crossed Below MA(7) | Set Alert |
|
Monday, October 20, 2025 11:25 PM
NovaBay Pharmaceuticals (NYSE:NBY) has formally regained compliance with the NYSE American's continued listing standards, successfully resolving deficiencies first cited in April and May 2024. The ...
|
|
Friday, October 10, 2025 07:27 AM
In early trading on Friday, shares of Marvell Technology topped the list of the day's best performing components of the Nasdaq 100 index, trading up 4.2%. Year to date, Marvell Technology has lost ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 14/11/25 | 35.22 | 35.3095 | 35.22 | 35.26 | 82,917 |
| 13/11/25 | 35.36 | 35.36 | 35.26 | 35.28 | 190,591 |
| 12/11/25 | 35.48 | 35.48 | 35.40 | 35.43 | 179,021 |
| 11/11/25 | 35.41 | 35.47 | 35.41 | 35.45 | 75,188 |
| 10/11/25 | 35.37 | 35.43 | 35.3486 | 35.43 | 95,405 |
| 07/11/25 | 35.28 | 35.30 | 35.24 | 35.28 | 76,616 |
| 06/11/25 | 35.32 | 35.32 | 35.2705 | 35.29 | 95,770 |
| 05/11/25 | 35.26 | 35.28 | 35.2445 | 35.28 | 70,895 |
| 04/11/25 | 35.21 | 35.27 | 35.19 | 35.27 | 143,041 |
| 03/11/25 | 35.39 | 35.39 | 35.26 | 35.27 | 128,938 |
|
|
||||
|
|
||||
|
|